000 01343 a2200373 4500
005 20250513042142.0
264 0 _c19950612
008 199506s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1995.tb04425.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan den Borne, B E
245 0 0 _aRelative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cFeb 1995
300 _a172-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_xmetabolism
650 0 4 _aBiological Availability
650 0 4 _aCapsules
650 0 4 _aCyclosporine
_xadministration & dosage
650 0 4 _aEmulsions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aLandewé, R B
700 1 _aGoei The, H S
700 1 _aMattie, H
700 1 _aBreedveld, F C
700 1 _aDijkmans, B A
773 0 _tBritish journal of clinical pharmacology
_gvol. 39
_gno. 2
_gp. 172-5
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1995.tb04425.x
_zAvailable from publisher's website
999 _c7741525
_d7741525